Recall Register

Food, drugs, devices › OPTI Medical Systems, Inc

Device recall: BP7561 OPTI CCA-TS B-Lac Cassette (25 per box) Cassettes are consumables used in the OPTI CCA-TS Analyzer intended to be

FDA enforcement event 62606 · Class II · initiated 3 Jul 2012 · status Terminated · terminated 11 Apr 2013

DeviceVoluntary: Firm initiated1 product recordRoswell, GA

FDA enforcement event 62606 is a device recall by OPTI Medical Systems, Inc of Roswell, GA, initiated 3 Jul 2012 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 11 Apr 2013. Initiation: voluntary: firm initiated. OPTI Medical Systems, Inc has 3 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

OPTI Medical Systems, Inc, Roswell, GA.

Reason for recall

"The values reported for PCO2 by BP7561 B-Lac cassettes are biased at high concentrations when used at altitudes above 2800 feet (853 meters)."

Distribution

"Worldwide Distribution -- US (nationwide) including the states of AZ, ID, TX and UT., and the countries of Argentina, Bolivia, China, Ecuador, France, Germany Greece, India, Indonesia, Iran,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2440-2012BP7561 OPTI CCA-TS B-Lac Cassette (25 per box) Cassettes are consumables used in the OPTI CCA-TS Analyzer intended to be used for in vitro measurements of pH, PCOX2 PO2, lactate (lactic acid), total hemoglobin (tHb), and oxygen saturation (SO2), in heparinized whole blood samples (either arterial or venous) on the…895 boxes (25 cassettes per box)Class IITerminated3 Oct 2012

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
3events on this register for the firm

Other enforcement events for OPTI Medical Systems, Inc

InitiatedProduct (first record)TypeClassRecords
25 Jun 2021OPTI SARS-CoV-2 RT-PCR Test, REF Numbers: a) 99-57003 b) 99-57004DeviceClass II1
9 Aug 2013Model BP7507 OPTI LION E-Plus Cassettes 25 Cassettes with Sample Probes, OPTIMedical Cassettes are consumable used in thDeviceClass II1

All 3 events for OPTI Medical Systems, Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The values reported for PCO2 by BP7561 B-Lac cassettes are biased at high concentrations when used at altitudes above 2800 feet (853 meters)."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution -- US (nationwide) including the states of AZ, ID, TX and UT., and the countries of Argentina, Bolivia, China, Ecuador, France, Germany Greece, India, Indonesia, Iran,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 11 Apr 2013. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.